Shattuck Labs, Inc. (STTK) stock
STTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.59−0.07 (-1.50%)
Close on Nov 17, 2026Market cap $460.67MP/E –Yield –
Shattuck Labs operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Shattuck Labs's operating income for the twelve months ending Jun 30, 2026 was -$55.79M. For fiscal 2025 it was -$51.51M. The highest annual figure on record is -$25.07M in fiscal 2019.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$51.51M | – |
| FY2024 | Dec 31, 2024 | -$80.57M | – |
| FY2023 | Dec 31, 2023 | -$91.96M | – |
| FY2022 | Dec 31, 2022 | -$103.33M | – |
| FY2021 | Dec 31, 2021 | -$45.27M | – |
| FY2020 | Dec 31, 2020 | -$36.93M | – |
| FY2019 | Dec 31, 2019 | -$25.07M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$16.16M | – |
| Q1 FY2026 | Mar 31, 2026 | -$15.55M | – |
| Q4 FY2025 | Dec 31, 2025 | -$13.37M | – |
| Q3 FY2025 | Sep 30, 2025 | -$10.72M | – |
| Q2 FY2025 | Jun 30, 2025 | -$13.03M | – |
| Q1 FY2025 | Mar 31, 2025 | -$14.39M | – |
| Q4 FY2024 | Dec 31, 2024 | -$19.64M | – |
| Q3 FY2024 | Sep 30, 2024 | -$17.92M | – |
| Q2 FY2024 | Jun 30, 2024 | -$22.96M | – |
| Q1 FY2024 | Mar 31, 2024 | -$20.04M | – |
| Q4 FY2023 | Dec 31, 2023 | -$18.95M | – |
| Q3 FY2023 | Sep 30, 2023 | -$28.60M | – |
| Q2 FY2023 | Jun 30, 2023 | -$22.75M | – |
| Q1 FY2023 | Mar 31, 2023 | -$21.66M | – |
| Q4 FY2022 | Dec 31, 2022 | -$26.28M | -384.2% |
| Q3 FY2022 | Sep 30, 2022 | -$25.23M | – |
| Q2 FY2022 | Jun 30, 2022 | -$27.66M | – |
| Q1 FY2022 | Mar 31, 2022 | -$24.17M | – |
| Q4 FY2021 | Dec 31, 2021 | $9.25M | – |
| Q3 FY2021 | Sep 30, 2021 | -$17.58M | – |
| Q2 FY2021 | Jun 30, 2021 | -$24.51M | – |
| Q1 FY2021 | Mar 31, 2021 | -$12.42M | – |
| Q4 FY2020 | Dec 31, 2020 | -$12.01M | – |
| Q3 FY2020 | Sep 30, 2020 | -$11.84M | – |
| Q2 FY2020 | Jun 30, 2020 | -$6.32M | – |
| Q1 FY2020 | Mar 31, 2020 | -$6.76M | – |
| Q4 FY2019 | Dec 31, 2019 | -$7.62M | – |
| Q3 FY2019 | Sep 30, 2019 | -$7.53M | – |
See a number that looks wrong?